Period Ending June 3_ 2011 - College of Pharmacy by pengxiuhui


									                         “In the News” May 21 – June 3, 2011

Drug & Pharmacy-related Literature Behind Recent News Headlines – Hyperlinked
                 to Abstracts, News Articles & Documents &
           Brought to You by the Dalhousie Pharmacy Library Team

Press release: First Lady, Agriculture Secretary launch MyPlate Icon as a new reminder to help
consumers to make healthier food choices. Washington DC: United States Department of Agriculture;
June 2, 2011.

                           By & About Faculty, Students, Alumni and Friends

Agu R, MacDonald C, Cowley E, Shao D, Renton K, Clarke DB, Massoud E. Differential expression of
organic cation transporters in normal and polyps human nasal epithelium: implications for in vitro drug
delivery studies. Int J Pharm. 2011 Mar 15;406(1-2):49-54. Epub 2011 Jan 8.

Sa AS, Nj M, N M, E G, Pj Z. Adverse events related to medications identified by a Canadian poison
centre. J Popul Ther Clin Pharmacol. 2011;18(2):e250-6. Epub 2011 May 2.

The following two articles were co-authored by Heather K. Naylor, a 2009 Dal Pharmacy grad:

        Naylor HK, Raymond CB. Treatment of neuropathic pain in patients with chronic kidney disease.
        CANNT J. 2011 Jan-Mar;21(1):34-8; quiz 39-40.

        Raymond CB, Naylor HK. Smoking cessation in patients with chronic kidney disease. CANNT J.
        2010 Oct-Dec;20(4):24-9; quiz 30-1.
                                Basic Sciences Research Related to Drugs

The commentary is related to the study that follows:

        Paul SM. Therapeutic antibodies for brain disorders. Sci Transl Med. 2011 May 25;3(84):84ps20.

        Atwal JK, Chen Y, Chiu C et al. A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-{beta}
        Production in Vivo. Sci Transl Med. 2011 May 25;3(84):84ra43.

                                         Cardiovascular Diseases

{blacktriangledown}Ticagrelor for acute coronary syndrome? Drug Ther Bull. 2011 Jun;49(6):66-8.
(Ticagrelor (Brilinta by AstraZenaca Canada) received in Notice of Compliance from Health Canada on
May 30, 2011.)

Raju N, Sobieraj-Teague M, Hirsh J et al. Effect of Aspirin on Mortality in the Prevention of
Cardiovascular Disease. Am J Med. 2011May 16. [Epub ahead of print].

Pizzi C, Rutjes AW, Costa GM et al. Meta-analysis of selective serotonin reuptake inhibitors in patients
with depression and coronary heart disease. Am J Cardiol. 2011 Apr 1;107(7):972-9. Epub 2011 Jan 20.

Bavry AA, Khaliq A, Gong Y et al. Harmful Effects of Nonsteroidal Anti-inflammatory Drugs among
Patients with Hypertension and Coronary Artery Disease. Am J Med. 2011 May 17. [Epub ahead of print].

The following study and commentary are related:

        Choudhry NK, Fischer MA, Avorn J et al. The implications of therapeutic complexity on
        adherence to
        cardiovascular medications. Arch Intern Med. 2011 May 9;171(9):814-22.

        Salanitro AH, Kripalani S. Prescription refill management and its effect on adherence: comment
        on "the implications of therapeutic complexity on adherence to cardiovascular medications".
        Arch Intern Med. 2011 May 9;171(9):822-3. Epub 2011Jan 10.

Marx G, Witte N, Himmel W et al. Accepting the unacceptable: Medication adherence and different
types of action patterns among patients with high blood pressure. Patient Educ Couns. 2011 May 18.
[Epub ahead of print].

Rayman MP, Stranges S, Griffin BA et al. Effect of supplementation with high-selenium yeast on plasma
lipids: a randomized trial. Ann Intern Med. 2011 May 17;154(10):656-65

Charlot M, Grove EL, Hansen PR et al. Proton pump inhibitor use and risk of adverse cardiovascular
events in aspirin treated patients with first time myocardial infarction: nationwide propensity score
matched study. BMJ. 2011 May 11;342:d2690. doi: 10.1136/bmj.d2690.

Schjerning Olsen AM, Fosbøl EL et al. Duration of treatment with nonsteroidal anti-inflammatory drugs
and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial
infarction: a nationwide cohort study. Circulation. 2011 May 24;123(20):2226-35. Epub 2011 May 9.
 Schmidt M, Christiansen CF, Horvath-Puhó E et al. Nonsteroidal anti-inflammatory drug use and risk of
venous thromboembolism. J Thromb Haemost. 2011 May 19. doi: 10.1111/j.1538-7836.2011.04354.x.
[Epub ahead of print].

West AM, Anderson JD, Meyer CH et al. The effect of ezetimibe on peripheral arterial atherosclerosis
depends upon statin use at baseline. Atherosclerosis. 2011 Apr 16. [Epub ahead of print].

The following study and commentary are related:

        McAlister FA, Wilkins K, Joffres M et al. Changes in the rates of awareness, treatment and
        control of hypertension in Canada over the past two decades. CMAJ. 2011 May 16.

        Chobanian AV. Major improvements in the control of hypertension in Canada. CMAJ. 2011 May

Schjerning Olsen AM, Fosbøl EL, Lindhardsen J et al. Duration of treatment with nonsteroidal anti-
inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with
prior myocardial infarction: a nationwide cohort study. Circulation. 2011 May 24;123(20):2226-35.

Zhang L, Zhang S, Jiang H et al. Effects of statin treatment on cardiac function in patients with chronic
heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2011 Feb;34(2):117-23. doi:
10.1002/clc.20821. Epub 2010 Dec 10.

Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian
perspective. Can Fam Physician. 2011 Apr;57(4):417-23.

Wann LS, Curtis AB, Ellenbogen KA, ... American College of Cardiology Foundation/American Heart
Association Task Force. (2011). ACCF/AHA/HRS focused update on the management of patients with
atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology
Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar

Fuster V, Rydén LE, Cannom DS, … American College of Cardiology Foundation/American Heart
Association Task Force. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006
guidelines for the management of patients with atrial fibrillation: a report of the American College of
Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011
Mar 15;123(10):e269-367.


Hoody DW, Beckett CF, Zielenski C, Moore GD. Quality of drug information database research for clinical
decision support. Int J Clin Pharm. 2011 May 19. [Epub ahead of print].

Larochelle JM, King AR, Tanas M et al. Writing a review article. Am J Health Syst Pharm. 2011 May

Vanderweele TJ, Knol MJ. Interpretation of subgroup analyses in randomized trials: heterogeneity versus
secondary interventions. Ann Intern Med. 2011 May 17;154(10):680-3.
Taljaard M, McRae AD, Weijer C, Bennett C, et al. Inadequate reporting of research ethics review and
informed consent in cluster randomised trials: review of random sample of published trials. BMJ. 2011
May 11;342:d2496. doi: 10.1136/bmj.d2496.

Ledford H. Therapeutic success stifles medical progress. Nature. 2011 May 26;473(7348):433.

Gøtzsche PC, Jørgensen AW. Opening up data at the European Medicines Agency. BMJ. 2011 May
10;342:d2686. doi: 10.1136/bmj.d2686.

Barbui C, Baschirotto C, Cipriani A. EMA must improve the quality of its clinical trial reports. BMJ. 2011
May 25;342:d2291. doi: 10.1136/bmj.d2291.

Moynihan R. It's time to rebuild the evidence base. BMJ. 2011 May 25;342:d3004.doi:

Synetos A, Toutouzas K, Karanasos A et al. Differences in Drug-Eluting Stents Used in Coronary
Artery Disease. Am J Med Sci. 2011 May 27. [Epub ahead of print].

Akl EA, Oxman AD, Herrin J et al. Using alternative statistical formats for presenting risks
and risk reductions. Cochrane Database Syst Rev. 2011 Mar 16;3:CD006776.

                                        Cerebrovascular Diseases

Saposnik G, Barinagarrementeria F, Brown RD Jr et al for the American Heart Association Stroke
Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous
thrombosis: a statement for healthcare professionals from the American Heart Association/American
Stroke Association. Stroke. 2011Apr;42(4):1158-92. Epub 2011 Feb 3.

Mackey J, Kleindorfer D, Sucharew H, et al. Population-based study of wake-up strokes. Neurology.
2011 May 10;76(19):1662-7.

Ogilvie IM, Welner SA, Cowell W, Lip GY. Ischaemic stroke and bleeding rates in 'real-world' atrial
fibrillation patients. Thromb Haemost. 2011 May 26;106(1).


Cipriani A, Barbui C, Butler R, Hatcher S, Geddes J. Depression in adults: drug and physical treatments.
Clin Evid (Online). 2011 May 25;2011. pii: 1003.

Maheu FS, Joober R, Lupien SJ. Declarative memory after stress in humans: differential involvement of
the beta-adrenergic and corticosteroid systems. J Clin Endocrinol Metab. 2005 Mar;90(3):1697-704.
Epub 2004 Dec 7.

Vigen CL, Mack WJ, Keefe RS et al. Cognitive Effects of Atypical Antipsychotic Medications in Patients
With Alzheimer's Disease: Outcomes From CATIE-AD. Am J Psychiatry. 2011 May 15. [Epub ahead of
Ruberg SJ, Chen L, Stauffer V et al. Identification of early changes in specific symptoms that predict
longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia. BMC
Psychiatry. 2011 Feb 9;11:23.

The following review and editorial are related:

         Raz A, Campbell N, Guindi D et al. Placebos in clinical practice: comparing attitudes, beliefs,
         and patterns of use between academic psychiatrists and nonpsychiatrists. Can J Psychiatry.
         2011 Apr;56(4):198-208.

         Kirsch I. The use of placebos in clinical trials and clinical practice. Can J Psychiatry. 2011

Rush AJ, Trivedi MH, Stewart JW et al. Combining Medications to Enhance Depression Outcomes (CO-
MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study. Am J Psychiatry.
2011 May 2.

Gartlehner G, Hansen RA, Reichenpfader U et al. Drug Class Review: Second-Generation
Antidepressants: Final Update 5 Report [Internet]. Portland (OR): Oregon Health & Science University;
2011 Mar.

Cabrera-Abreu C. It is now Personal: Recent Views on the Assessment of Therapeutic Infidelity in Severe
Mental Illness. Curr Clin Pharmacol. 2011 May 19.

Gunderson JG. Clinical practice. Borderline personality disorder. N Engl J Med. 2011 May

Hamed SA. Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic
medications. Expert Opin Drug Saf. 2011 May 28. [Epub ahead of print].

Ball MP, Warren KR, Feldman S et al. Placebo-controlled trial of atomoxetine for weight reduction in
people with schizophrenia treated with clozapine or olanzapine. Clin Schizophr Relat Psychoses. 2011

Swartz HA, Thase ME. Pharmacotherapy for the treatment of acute bipolar II depression: current
evidence. J Clin Psychiatry. 2011 Mar;72(3):356-66. Epub 2010 Aug 10.

           Cochrane Reviews: Recently Published and of Particular Interest to Pharmacists

Ryan R, Santesso N, Hill S et al. Consumer-oriented interventions for evidence-based prescribing and
medicines use: an overview of systematic reviews. Cochrane Database Syst Rev. 2011 May

                             Complementary & Alternative Medicine (CAM)

Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011
Apr;15(2):99-106. Epub 2010 Jun 8.
Janssen IM, Sturtz S, Skipka G et al. Ginkgo biloba in Alzheimer's disease: a systematic review. Wien
Med Wochenschr. 2010 Dec;160(21-22):539-46.


Brondani M, Park PE. Methadone and oral health - a brief review. J Dent Hyg. 2011;85(2):92-8.

Thornhill MH, Dayer MJ, Forde JM et al. Impact of the NICE guideline recommending cessation of
antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011 May


Eaglstein WH, Corcoran G. New drugs and new molecular entities in dermatology. Arch Dermatol. 2011

Montaudié H, Sbidian E, Paul C et al. Methotrexate in psoriasis: a systematic review of treatment
modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol. 2011

Sbidian E, Maza A, Montaudié H et al. Efficacy and safety of oral retinoids in different psoriasis
subtypes: a systematic literature review. J Eur Acad Dermatol Venereol. 2011 May;25 Suppl 2:28-33

Maza A, Montaudié H, Sbidian E et al. Oral cyclosporin in psoriasis: a systematic review on treatment
modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol
Venereol. 2011 May;25 Suppl 2:19-27.

The following two articles are related:

        Sunscreen SPFs: clear as daylight? Drug Ther Bull. 2011 Jun;49(6):61.

        Do sunscreens have a role in preventing skin cancer? Drug Ther Bull. 2011 Jun;49(6):69-72.

Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and
terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011 Apr;64(4):663-70. Epub 2011 Feb


Bennett WL, Wilson LM, Bolen S et al. Oral Diabetes Medications for Adults With Type 2 Diabetes: An
Update. Comparative Effectiveness Review No. 27. (Prepared by Johns Hopkins University Evidence-
based Practice Center under Contract No. 290-02-0018.) AHRQ Publication No. 11-EHC038-EF. Rockville,
MD: Agency for Healthcare Research and Quality. March 2011.

Nicholson G, Hall GM. Diabetes mellitus: new drugs for a new epidemic. Br J Anaesth. 2011 May 24.
Jonas D, Van Scoyoc E, Gerrald K et al. Drug Class Review: Newer Diabetes Medications, TZDs, and
Combinations: Final Original Report [Internet]. Portland (OR): Oregon Health & Science University; 2011

Schramm TK, Gislason GH, Vaag A et al. Mortality and cardiovascular risk associated with different
insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous
myocardial infarction: a nationwide study. Eur Heart J. 2011 Apr 6. [Epub ahead of print].

                         Drug Compounding, Biopharmaceutics & Drug Industry

Buanz AB, Saunders MH, Basit AW, Gaisford S. Preparation of Personalized-dose Salbutamol Sulphate
Oral Films with Thermal Ink-Jet Printing. Pharm Res. 2011 May 5. [Epub ahead of print].

Weiss RA, Voigts R, Howell DJ. Absence of concentration congruity in six compounded polidocanol
samples obtained for leg sclerotherapy. Dermatol Surg. 2011 Jun;37(6):812-5.

Fox LM, Foushee JA, Jackson DJ, Watson H. Visual compatibility of common nebulizer medications with
7% sodium chloride solution. Am J Health Syst Pharm. 2011 Jun 1;68(11):1032-5.

Phillips NM, Endacott R. Medication administration via enteral tubes: a survey of nurses' practices. J Adv
Nurs. 2011 May 19.

Betz UA. Portfolio management in early stage drug discovery - a traveler's guide through uncharted
territory. Drug Discov Today. 2011 May 11.

Franklin SL. Effects of unintentional exposure of children to compounded transdermal sex hormone
therapy. Pediatr Endocrinol Rev. 2011 Mar;8(3):208-12.
Pradeep AR, Sharma A. "Clinical Efficacy of 1% Alendronate Gel as Local Drug Delivery System in the
Treatment of Chronic Periodontitis - A Randomized Controlled Clinical Trial". J Periodontol. 2011 May 4.

Ledford H. Therapeutic success stifles medical progress. Nature. 2011 May 26;473(7348):433.

Yao L, Zhang Y, Li Y et al. Electronic health records: implications for drug discovery. Drug Discov Today.
2011 May 23. [Epub ahead of print].

Liu D. Where do new medicines come from? CBE Life Sci Educ. 2011 Summer;10(2):135-41.

                            Drug Safety, Medication Errors & Patient Safety

Figueredo VM. Chemical cardiomyopathies: the negative effects of medications and nonprescribed
drugs on the heart. Am J Med. 2011 Jun;124(6):480-8.

Monitoring MedWatcch reports: New signals for liraglutide, quetiapine and varenicline. QuarterWatch:
2010 Quarter 3. Horsham PA: Institute for Safe Medication Practices; May 19, 2011.

Small GR, Chow BJ, So DY. Coprescription of clopidogrel and proton pump inhibitors. BMJ. 2010 Nov
Ranchon F, Vantard N, Gouraud A et al. Suspicion of Drug-Drug Interaction between High-Dose
Methotrexate and Proton Pump Inhibitors: A Case Report - Should the Practice Be Changed?
Chemotherapy. 2011 May 18;57(3):225-229.

Eom CS, Park SM, Myung SK et al. Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of
Observational Studies. Ann Fam Med. 2011 May-Jun;9(3):257-67.

Sarkar U, López A, Maselli JH, Gonzales R. Adverse Drug Events in U.S. Adult Ambulatory Medical Care.
Health Serv Res. 2011 May 10.

King JP, Davis TC, Bailey SC et al. Developing consumer-centered, nonprescription drug labeling a study
in acetaminophen. Am J Prev Med. 2011 Jun;40(6):593-8.

Tatonetti NP, Denny JC, Murphy SN et al. Detecting Drug Interactions From Adverse-Event Reports:
Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels. Clin Pharmacol Ther.
2011 May 25. [Epub ahead of print].

Goodman A, Schorge J, Greene MF. The long-term effects of in utero exposures--the DES story. N Engl J
Med. 2011 Jun 2;364(22):2083-4. Epub 2011 Apr 20.

                                      Emergency, Critical Care & ICU

Jefferies S, Weatherall M, Young P et al. The effect of antipyretic medications on mortality in critically ill
patients with infection: a systematic review and meta-analysis. Crit Care Resusc. 2011 Jun;13(2):125-31.

                                            Endocrine Diseases

Al-Azem H, Khan A. Primary hyperparathyroidism. CMAJ. 2011 Apr 26. [Epub ahead of print].

                                 Environmental & Occupational Concerns

Press release No. 208: IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to
humans. Lyon FR: World Health Organization; May 31, 2011.

Gutschi T, Mohamad Al-Ali B, Shamloul R et al. Impact of cell phone use on men's semen parameters.
Andrologia. 2011 Mar 28. doi:10.1111/j.1439-0272.2010.01075.x. [Epub ahead of print].

Christodouleas JP, Forrest RD, Ainsley CG et al. Short-Term and Long-Term Health Risks of Nuclear-
Power-Plant Accidents. N Engl J Med. 2011 Apr 20. [Epub ahead of print].


Tzellos TG, Toulis KA, Goulis DG et al. Gabapentin and pregabalin in the treatment of fibromyalgia: a
systematic review and a meta-analysis. J Clin Pharm Ther. 2010 Dec;35(6):639-56. doi:

Ngian GS, Guymer EK, Littlejohn GO. The use of opioids in fibromyalgia. Int J Rheum Dis. 2011
Feb;14(1):6-11. doi: 10.1111/j.1756-185X.2010.01567.x. Epub 2010Aug 23.
                                        Gastrointestinal Diseases

Crowe SE. Celiac disease. Ann Intern Med. 2011 May 3;154(9):ITC51.

Galmiche JP, Hatlebakk J, Attwood S et al for the LOTUS Trial Collaborators. Laparoscopic antireflux
surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.
JAMA. 2011 May 18;305(19):1969-77.

Lees, M, Begier, L, and Jensen, B. (2011). Navigating the complexity of ulcerative colitis
Challenging case example. Canadian Family Physician, 57(5), 568-572.

Pluta RM, Perazza GD, Golub RM. JAMA patient page. Gastroesophageal reflux disease. JAMA. 2011 May

Kwok R. Vaccines: The real issues in vaccine safety. Nature. 2011 May 26;473(7348):436-8.

Kesselheim A. Safety, supply, and suits--litigation and the vaccine industry. N Engl J Med. 2011 Apr

Modern heroes. Nature. 2011 May 26;473(7348):420.


Huisman-Baron M, van der Veen L, Jansen PA el al. Criteria for drug selection in frail elderly persons.
Drugs Aging. 2011 May 1;28(5):391-402. doi: 10.2165/11587200-000000000-00000.

Fried TR, Tinetti ME, Towle V et al. Effects of benefits and harms on older persons' willingness to take
medication for primary cardiovascular prevention. Arch Intern Med. 2011 May 23;171(10):923-8. Epub
2011 Feb 28.

Cho S, Lau SW, Tandon V et al. Geriatric drug evaluation: where are we now and where should we be in
the future? Arch Intern Med. 2011 May 23;171(10):937-40.

Mittal V, Kurup L, Williamson D et al. Risk of cerebrovascular adverse events and death in elderly
patients with dementia when treated with antipsychotic medications: a literature review of evidence.
Am J Alzheimers Dis Other Demen. 2011 Feb;26(1):10-28.

Klopotowska JE, Wierenga PC, de Rooij SE et al. The effect of an active on-ward participation of hospital
pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients:
protocol of the WINGS study (Ward-oriented pharmacy In Newly admitted Geriatric Seniors). BMC
Health Serv Res. 2011 May 25;11(1):124. [Epub ahead of print].

Sterke CS, van Beeck EF, van der Velde N et al. New Insights: Dose-Response Relationship Between
Psychotropic Drugs and Falls: A Study in Nursing Home Residents With Dementia. J Clin Pharmacol. 2011
May 31. [Epub ahead of print].
Brass EP, Sietsema KE. Considerations in the development of drugs to treat sarcopenia. J Am Geriatr Soc.
2011 Mar;59(3):530-5. doi: 10.1111/j.1532-5415.2010.03285.x.

                                             Global Health

Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis. BMJ. 2011 May
17;342:d2651. doi: 10.1136/bmj.d2651.

van Ommeren M, Barbui C, de Jong K et al. If you could only choose five psychotropic medicines:
updating the interagency emergency health kit. PLoS Med. 2011 May;8(5):e1001030. Epub 2011 May 3.

 Allen T, Parker M. The "other diseases" of the Millennium Development Goals: rhetoric and reality of
free drug distribution to cure the poor's parasites. Third World Q. 2011;32(1):91-117.

                                       Immune System Diseases

Golden DB, Moffitt J, Nicklas RA et al for the Joint Task Force on Practice Parameters; American
Academy of Allergy, Asthma & Immunology (AAAAI); American College of Allergy, Asthma &
Immunology (ACAAI); Joint Council of Allergy, Asthma and Immunology. Stinging insect hypersensitivity:
a practice parameter update 2011. J Allergy Clin Immunol. 2011 Apr;127(4):852-4.e1-23.

                                       Immunizations & Vaccines

Vezali E, Aghemo A, Colombo M. Interferon in the treatment of chronic hepatitis C: a drug caught
between past and future. Expert Opin Biol Ther. 2011Mar;11(3):301-13. Epub 2011 Jan 21.

                                           Infectious Diseases

Heidari S, Mofenson L, Cotton MF et al. Antiretroviral Drugs for Preventing Mother-to-Child
Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children. J Acquir
ImmuneDefic Syndr. 2011 May 11. [Epub ahead of print].

Boyd SD. Management of HIV infection in treatment-naive patients: A review of the most current
recommendations. Am J Health Syst Pharm. 2011 Jun 1;68(11):991-1001.

Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 Infection. N Engl J Med. 2011 May

Allen U. Infective endocarditis: Updated guidelines. Can J Infect Dis Med Microbiol. 2010

                                            Kidney Diseases

Jones GR. Estimating renal function for drug dosing decisions. Clin Biochem Rev. 2011 May;32(2):81-8.

Doogue MP, Polasek TM. Drug dosing in renal disease. Clin Biochem Rev. 2011 May;32(2):69-73.
                                               Men’s Health

Tan N, Klein EA, Li J et al. Statin Use and Risk of Prostate Cancer in a Population of Men Who Underwent
Biopsy. J Urol. 2011 May 13. [Epub ahead of print].

Sexual dysfunction as the last bastion of urological drug commercialization within the pharmaceutical
industry. BJU Int. 2011 Jun;107(11):1845-6. doi:10.1111/j.1464-410X.2011.10348.x.

                                        Musculoskeletal Diseases

Audran M, Cortet B, Thomas T; On behalf of the Bone division of the French Society for Rheumatology.
What do we know about atypical femoral fractures? Insights and enigmas. Joint Bone Spine. 2011 May
16. [Epub ahead of print].

Orchard J, Kountouris A. The management of tennis elbow. BMJ. 2011 May 10;342:d2687. doi:


Oliver BJ, Kohli E, Kasper LH. Interferon therapy in relapsing-remitting multiple sclerosis: a systematic
review and meta-analysis of the comparative trials. J Neurol Sci. 2011 Mar 15;302(1-2):96-105. Epub
2010 Dec 16.

Wong J, Gomes T, Mamdani M et al. Adherence to Multiple Sclerosis Disease-Modifying Therapies in
Ontario is Low. Can J Neurol Sci. 2011 May;38(3):429-33.

Lasoo W, Dudra-Jastrzębska M, Rejdak K, Czuczwar SJ. Basic mechanisms of antiepileptic drugs and their
pharmacokinetic/pharmacodynamic interactions: an update. Pharmacol Rep. 2011 Mar-Apr;63(2):271-

                                              News – Canada

Meili R. SaskPharm: a proposal for provincial drug production. CMAJ. 2011 May 24. [Epub ahead of

Quebec's new cancer drug approval process criticized. June 3, 2011.

In Hansard ... Personal care homes and national drug plan in Newfoundland and Labrador . June 3, 2011.

In Hansard ... Catastrophic drug program in New Brunswick. June 3, 2011.

Shortage of cancer drugs causes concerns. May 20, 2011.

Quebec changing approval process for cancer drugs. May 21, 2011
                                          News – International

Nichols M. Global war on drugs a failure, high-level panel says. Reuters. June 2, 2011.

Reuters. France pulls subsidy for Pfizer stop-smoking drug. FOREXYARD. June 1, 2011.

Kupferschmidt K. More placebo use promoted in Germany. CMAJ. 2011 May 24.

Kelland, K. Smoking could kill 8 million a year by 2030: WHO. Reuters. May 31, 2011.

                                               News – US

Tocknell MD. Oral cancer drugs deserve parity. HealthLeaders Media. May 25, 2011.

Neergaard L. Hospitals hunt substitutes as drug shortages rise. Denver Post. May 31, 2011.

Nichols M. Drug companies drive U.S. 2010 corporate philanthropy. Reuters. Accessed June 2, 2011.

Juva T. Critical drug shortages challenge local hospitals. May 25, 2011.

Waters R. Drug-resistant germs lure biotechs to lead antibiotics effort. Bloomberg. May 17, 2011.

Pollack A. The hidden price of drugs. New York Times. May 31, 2011.

News release: NIH stops clinical trial on combination cholesterol treatment: Lack of efficacy in reducing
cardiovascular events prompts decision. Bethesday MD: National Institutes of Health; May 26, 2011.

Williams T. Under an arizona plan, smokers and obese would pay fee for Medicaid. The New York Times.
Accessed June 2, 2011.

Mcneil DG. AIDS: a price break for antiretroviral drugs in 70 of the world’s poorest countries. The New
York Times. Accessed June 2, 2011.

Feeley J, Yasiejko C. J&J Unit ordered to pay $10 million over Motrin injuries. Bloomberg. Accessed June
2, 2011.

Kulkarni, SS. States cut back efforts to provide drugs for HIV, AIDS. The Washington Post. Accessed
June 2, 2011.

Johnson LA, Associated Press. Bayer hopes fast-acting aspirin rejuvenates pain relief sales and attracts
younger users. Minneapolis Star Tribune. May 23, 2011.

The High Cost of Cheap Meat. New York Times. June 2, 2011.

Bloomberg News. U.S. Orders Review of Risks of Some Birth Control Pills. New York Times. May 31,
                                       Nutrition & Lifestyle Topics

Smithers LG, Gibson RA, Makrides M. Maternal supplementation with docosahexaenoic acid during
pregnancy does not affect early visual development in the infant: a randomized controlled trial. Am J
Clin Nutr. 2011 Jun;93(6):1293-9. Epub 2011 Apr 13.

Hempel S, Newberry S, Ruelaz A et al. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease.
Evidence Report/Technology Assessment No. 200. (Prepared by the Southern California Evidence-based
Practice Center under Contract No. 290-2007-10062-I.) AHRQ Publication No. 11-E007. Rockville, MD:
Agency for Healthcare Research and Quality. April 2011.

Reid IR, Avenell A. Evidence-based policy on dietary calcium and vitamin D. J Bone Miner Res. 2011
Mar;26(3):452-4. doi: 10.1002/jbmr.327.

Mason C, Xiao L, Imayama I et al. Effects of weight loss on serum vitamin D in postmenopausal women.
Am J Clin Nutr. 2011 May 25. [Epub ahead of print].

He K, Du S, Xun P et al. Consumption of monosodium glutamate in relation to incidence of overweight
in Chinese adults: China Health and Nutrition Survey (CHNS). Am J Clin Nutr. 2011 Jun;93(6):1328-36.
Epub 2011 Apr 6.

Warensjö E, Byberg L, Melhus H et al. Dietary calcium intake and risk of fracture and osteoporosis:
prospective longitudinal cohort study. BMJ. 2011 May 24;342:d1473. doi: 10.1136/bmj.d1473.

Conn VS, Hafdahl AR, Mehr DR. Interventions to increase physical activity among healthy adults: meta-
analysis of outcomes. Am J Public Health. 2011 Apr;101(4):751-8. Epub 2011 Feb 17.

Leung BM, Wiens KP, Kaplan BJ. Does prenatal micronutrient supplementation improve children's
mental development? A systematic review. BMC Pregnancy Childbirth. 2011 Feb 3;11:12.

                                Obesity, Weight Loss & Eating Disorders

Leykin Y, Miotto L, Pellis T. Pharmacokinetic considerations in the obese. Best Pract Res Clin
Anaesthesiol. 2011 Mar;25(1):27-36.

Jain R, Chung SM, Jain L et al. Implications of Obesity for Drug Therapy: Limitations and Challenges. Clin
Pharmacol Ther. 2011 Jun 1. [Epub ahead of print].

Han TS, Tajar A, Lean ME. Obesity and weight management in the elderly. Br Med Bull. 2011;97(1):169-
96. Epub 2011 Feb 16.

Correll CU, Lencz T, Malhotra AK. Antipsychotic drugs and obesity. Trends Mol Med. 2011 Feb;17(2):97-
107. Epub 2010 Dec 22.
                                       Obstetrics and Gynecology

Mitchell AA, Gilboa SM, Werler MM et al for the National Birth Defects Prevention Study. Medication
use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol.
2011 Apr 21. [Epub ahead of print].

Mølgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects.
JAMA. 2011 May 18;305(19):1996-2002.

The following study and editorial are realted:

        Vadillo-Ortega F, Perichart-Perera O, Espino S et al. Effect of supplementation during pregnancy
        with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk
        population: randomised controlled trial. BMJ. 2011 May 19;342:d2901. doi: 10.1136/bmj.d2901.

        Smeeth L, Williams D. Can a dietary supplement prevent pre-eclampsia? BMJ. 2011 May
        19;342:d2777. doi: 10.1136/bmj.d2777.

Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during
pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a
systematic review and metaanalysis. Am J Obstet Gynecol. 2011 Apr 27. [Epub ahead of print].

Bozzo P, Narducci A, Einarson A. Vaccination during pregnancy. Can Fam Physician. 2011 May;57(5):555-

Committee opinion no. 494: sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol.
2011 Jun;117(6):1484-5.

                                           On the Lighter Side

The news article refers to an announcement on the US CDC website:

        McNeil DG Jr, Harris G. Zombies upstage a routine public health bulletin. New York Times. May
        19, 2011.

        Social media: Preparedness 101: Zombie apocalypse. Atlanta GA: US Center for Disease
        Control and prevention; accessed May 20, 201.


Foulon V, Schöffski P, Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in
modern oncology. Acta Clin Belg. 2011 Mar-Apr;66(2):85-96.

Fleshner NE, Kapusta L, Donnelly B et al. Progression From High-Grade Prostatic Intraepithelial
Neoplasia to Cancer: A Randomized Trial of Combination Vitamin-E, Soy, and Selenium. J Clin Oncol.
2011 May 2. [Epub ahead of print].
Neugut AI, Subar M, Wilde ET et al. Association Between Prescription Co-Payment Amount and
Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer. J Clin
Oncol. 2011 May 23. [Epub ahead of print].

Van Poznak CH, Temin S, Yee GC et al for the American Society of Clinical Oncology. American Society of
Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-
modifying agents in metastatic breast cancer. J Clin Oncol. 2011 Mar 20;29(9):1221-7. Epub
2011 Feb 22.

Wilson KM, Kasperzyk JL, Rider JR et al. Coffee Consumption and Prostate Cancer Risk and
Progression in the Health Professionals Follow-up Study. J Natl Cancer Inst. 2011 May 17. [Epub ahead of


Penha FM, Rodrigues EB, Furlani BA et al. Toxicological considerations for intravitreal drugs. Expert Opin
Drug Metab Toxicol. 2011 Jun 1. [Epub ahead of print].

Noble J, Chaudhary V. Ranibizumab and the eye. CMAJ. 2011 Apr 19;183(7):822. Epub 2011 Feb 22.

The following study and editorial are related:

        CATT Research Group, Martin DF, Maguire MG, Ying GS et al. Ranibizumab and bevacizumab for
        neovascular age-related macular degeneration. N Engl J Med. 2011 May 19;364(20):1897-908.
        Epub 2011 Apr 28.

        Rosenfeld PJ. Bevacizumab versus ranibizumab for AMD. N Engl J Med. 2011 May
        19;364(20):1966-7. Epub 2011 Apr 28.

                                          Pain & Palliative Care

Berner T, Thomson H, Hartry A et al. A Comparison of Daily Average Consumption Of Oxycodone
Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With
Low Back Pain. P T. 2011 Mar;36(3):139-44.

The following review and commentary are related:

        Ernst E, Lee MS, Choi TY. Acupuncture: does it alleviate pain and are there serious risks? A
        review of reviews. Pain. 2011 Apr;152(4):755-64.

        Hall H. Acupuncture's claims punctured: not proven effective for pain, not harmless. Pain. 2011

The following two systematic reviews are related:

        van Middelkoop M, Rubinstein SM, Kuijpers T et al. A systematic review on the effectiveness of
        physical and rehabilitation interventions for chronic non-specific low back pain. Eur Spine J. 2011
        Jan;20(1):19-39. Epub 2010 Jul 18.
        Kuijpers T, van Middelkoop M, Rubinstein SM et al. A systematic review on the effectiveness of
        pharmacological interventions for chronic non-specific low-back pain. Eur Spine J. 2011
        Jan;20(1):40-50. Epub 2010 Jul 31.

Deer TR, Smith HS, Burton AW et al. Comprehensive Consensus Based Guidelines on Intrathecal Drug
Delivery Systems in the Treatment of Pain Caused by Cancer Pain. Pain Physician. 2011 May;14(3):E283-

Estfan B. Essential drugs in supportive care. Semin Oncol. 2011 Jun;38(3):413-23.


Perry R, Hunt K, Ernst E. Nutritional supplements and other complementary medicines for infantile colic:
a systematic review. Pediatrics. 2011Apr;127(4):720-33. Epub 2011 Mar 28.

The following study and comment are related:

        Molyneux E, Nizami SQ, Saha S et al for the CSF 5 Study Group. 5 versus 10 days of treatment
        with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence
        study. Lancet. 2011 May 28;377(9780):1837-45.

        Snape MD, Kelly DF. Fine with five? Shorter antibiotic courses for childhood meningitis. Lancet.
        2011 May 28;377(9780):1809-10.

Tabbers MM, Chmielewska A, Roseboom MG et al. Fermented Milk Containing Bifidobacterium
lactis DN-173 010 in Childhood Constipation: A Randomized, Double-Blind, Controlled Trial. Pediatrics.
2011 Jun;127(6):e1392-9. Epub 2011 May 23.

Church MK, Weller K, Stock P, Maurer M. Chronic spontaneous urticaria in children: itching for insight.
Pediatr Allergy Immunol. 2011 Feb;22(1 Pt 1):1-8. doi: 10.1111/j.1399-3038.2010.01120.x.

The following two studies and commentary are related:

        Paul IM, Maselli JH, Hersh AL et al. Antibiotic prescribing during pediatric ambulatory care visits
        for asthma. Pediatrics. 2011Jun;127(6):1014-21. Epub 2011 May 23.

        De Boeck K, Vermeulen F, Meyts I et al. Coprescription of antibiotics and asthma drugs in
        children. Pediatrics. 2011 Jun;127(6):1022-6. Epub 2011 May 23.

        Mangione-Smith R, Krogstad P. Antibiotic prescription with asthma medications: why is it so
        common? Pediatrics. 2011 Jun;127(6):1174-6. Epub 2011 May 23.

Long E, Pitfield AF, Kissoon N. Anticoagulation therapy: indications, monitoring, and complications.
Pediatr Emerg Care. 2011 Jan;27(1):55-61; quiz 62-4.

                Pharmacogenetics, Pharmacogenomics & Genetic (Inherited) Diseases
Carlquist JF, Anderson JL. Pharmacogenetic mechanisms underlying unanticipated drug responses.
Discov Med. 2011 May;11(60):469-78.

Jin B, Ni HC, Shen W et al. Cytochrome P450 2C19 polymorphism is associated with poor clinical
outcomes in coronary artery disease patients treated with clopidogrel. Mol Biol Rep. 2011
Mar;38(3):1697-702. Epub 2010 Sep 16.

Baer-Dubowska W, Majchrzak-Celioska A, Cichocki M. Pharmocoepigenetics: a new approach to
predicting individual drug responses and targeting new drugs. Pharmacol Rep. 2011 Mar-Apr;63(2):293-

                                          Pharmacy Practice

Schuh MJ, Crumb DJ, Dubois J. Building a pharmacist-managed pharmacotherapy medication therapy
management practice. Consult Pharm. 2011 Jun;26(6):404-13.

Khalil H. A review of pharmacist recommendations in an aged care facility. Aust J Prim Health.

Kellow N. Evaluation of a rural community pharmacy-based Waist Management Project: bringing the
program to the people. Aust J Prim Health. 2011;17(1):16-22.

O'Connor M, Fisher C, French L, Halkett G, Jiwa M, Hughes J. Exploring the community pharmacist's role
in palliative care: Focusing on the person not just the prescription. Patient Educ Couns. 2011 May 27.
[Epub ahead of print].

Hassell K, Seston EM, Schafheutle EI et al. Workload in community pharmacies in the UK and its impact
on patient safety and pharmacists' well-being: a review of the evidence. Health Soc Care Community.
2011 May 30. doi: 10.1111/j.1365-2524.2011.00997.x. [Epub ahead of print].

Warholak TL, Hines LE, Saverno KR et al. Assessment tool for pharmacy drug-drug interaction software.
J Am Pharm Assoc (2003). 2011 May-Jun;51(3):418-24.

Jiwa M, Sriram D, Khadaroo Z, Ping-Delfos WC. Could community pharmacies offer an opportunity to
improve outcomes for patients with bowel cancer? Qual Prim Care. 2011;19(2):105-8.

Perraudin C, Brion F, Bourdon O, Pelletier-Fleury N. The future of pharmaceutical care in France: a
survey of final-year pharmacy students' opinions. BMC Clin Pharmacol. 2011 May 25;11(1):6. [Epub
ahead of print].

Bennett MI, Bagnall AM, Raine G et al. Educational Interventions by Pharmacists to Patients With
Chronic Pain: Systematic Review and Meta-analysis. Clin J Pain. 2011 May 21. [Epub ahead of

Saokaew S, Permsuwan U, Chaiyakunapruk N et al. Effectiveness of pharmacist-participated warfarin
therapy management: a systematic review and meta-analysis. J Thromb Haemost. 2010 Nov;8(11):2418-
27. doi: 10.1111/j.1538-7836.2010.04051.x.
Skiles MP, Cai J, English A, Ford CA. Retail pharmacies and adolescent vaccination-an exploration of
current issues. J Adolesc Health. 2011 Jun;48(6):630-2.

Van Geffen EC, Philbert D, van Boheemen C et al. Patients' satisfaction with information and experiences
with counseling on cardiovascular medication received at the pharmacy. Patient Educ Couns. 2011 May

Evans CD, Watson E, Eurich DT et al. Diabetes and cardiovascular disease interventions by community
pharmacists: a systematic review. Ann Pharmacother. 2011 May;45(5):615-28.

Hogg G, Ker J, Stewart F. Over the counter clinical skills for pharmacists. Clin Teach. 2011 Jun;8(2):109-

Guirguis LM. Mixed methods evaluation: Pharmacists' experiences and beliefs toward an interactive
communication approach to patient interactions. Patient Educ Couns. 2011 May 30.

Shrank WH. Our bulging medicine cabinets--the other side of medication nonadherence. N Engl J Med.
2011 Apr 28;364(17):1591-3.

Latif A, Pollock K, Boardman HF. The contribution of the Medicines Use Review (MUR) consultation to
counseling practice in community pharmacies. Patient Educ Couns. 2011 May 27.

                                          Prescriptive Authority

Kroezen M, van Dijk L, Groenewegen PP, Francke AL. Nurse prescribing of medicines in Western
European and Anglo-Saxon countries: a systematic review of the literature. BMC Health Serv Res. 2011
May 27;11(1):127.

The following editorial and commentary are related:

        Courtenay M, Gerada C, Haywood J. Working with non-medical prescribers. Br J Gen Pract. 2011

        Pancholi K. Working with non-medical prescribers. Br J Gen Pract. 2011Mar;61(584):223.

                                        Respiratory Tract Diseases

The following study and invited commentary are related:

        Stephenson A, Seitz D, Bell CM et al. Inhaled anticholinergic drug therapy and the risk of acute
        urinary retention in chronic obstructive pulmonary disease: a population-based study. Arch
        Intern Med. 2011 May 23;171(10):914-20.

        Singh S, Furberg CD. Inhaled anticholinergics for chronic obstructive pulmonary disease:
        comment on "inhaled anticholinergic drug therapy and the risk of acute urinary retention in
        chronic obstructive pulmonary disease. Arch Intern Med. 2011 May 23;171(10):920-2.
Kawut SM, Bagiella E, Lederer DJ et al; on behalf of the ASA-STAT Study Group. Randomized Clinical Trial
of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT. Circulation. 2011 May 18.

Baroody FM, Brown D, Gavanescu L et al. Oxymetazoline adds to the effectiveness of fluticasone furoate
in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr;127(4):927-34.


The following report and editorial are related:

        Snijders GF, van den Ende CH, van Riel PL et al. The effects of doxycycline on reducing symptoms
        in knee osteoarthritis: results from a triple-blinded randomised controlled trial. Ann Rheum Dis.
        2011 Jul;70(7):1191-1196.

        Brandt KD. Why should we expect a structure-modifying osteoarthritis drug to relieve
        osteoarthritis pain? Ann Rheum Dis. 2011 Jul;70(7):1175-7.

                                              Sleep Disorders

Foral P, Knezevich J, Dewan N, Malesker M. Medication-induced sleep disturbances. Consult Pharm.
2011 Jun;26(6):414-25.

                                           Socioeconomic Topics

Brunton SA. Improving medication adherence in chronic disease management. J Fam Pract. 2011
Apr;60(4 Suppl Improving):S1-8.

Lavelle S, Tusaie KR. Reflecting on forced medication. Issues Ment Health Nurs. 2011;32(5):274-8.

Curfman GD, Morrissey S, Drazen JM. Prescriptions, privacy, and the First Amendment. N Engl J Med.
2011 May 26;364(21):2053-5. Epub 2011 Apr 27.

Smith TJ, Hillner BE. Bending the cost curve in cancer care. N Engl J Med. 2011 May 26;364(21):2060-5.

Austad KE, Avorn J, Kesselheim AS. Medical Students' Exposure to and Attitudes about the
Pharmaceutical Industry: A Systematic Review. PLoS Med. 2011 May;8(5):e1001037. Epub 2011 May 24.

Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence:
response to authors. J Clin Epidemiol. 2011 Mar;64(3):255-7; discussion 258-63. Epub 2010 Dec 8.

Miller FG, Brody H. Understanding and harnessing placebo effects: clearing away the underbrush. J Med
Philos. 2011 Feb;36(1):69-78. Epub 2011 Jan 10.

This news article refers to the report that follows:

        Picard A. Employers are clueless about the cost of their drug plans. Globe and Mail. June 1,
        Stevenson H. An end to blank cheques: Getting more value out of employer drug plans.
        Toronto ON: Reformulary Group; May 2011.

Curfman GD, Morrissey S, Drazen JM. Prescriptions, privacy, and the First Amendment. N Engl J Med.
2011 May 26;364(21):2053-5.

Oliver D. Teaching medical learners to appreciate “difficult” patients. Can Fam Physician. 2011

Aronsohn A, Jensen D. Distributive justice and the arrival of direct-acting antivirals: Who should be first
in line? Hepatology. 2011 Jun;53(6):1789-91.

Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and
reporting. BMJ. 2011 Apr 11;342:d1766.

Sulosaari V, Suhonen R, Leino-Kilpi H. An integrative review of the literature on registered nurses'
medication competence. J Clin Nurs. 2011 Feb;20(3-4):464-78.

Spiegel W, Mlczoch-Czerny MT, Jens R, Dowrick C. Quality circles for pharmacotherapy to modify general
practitioners' prescribing behaviour for generic drugs. J Eval Clin Pract. 2011 May 25.

Cain J. Social media in health care: The case for organizational policy and employee education. Am J
Health Syst Pharm. 2011 Jun 1;68(11):1036-40.

Gewin V. Social media: self-reflection, online. Nature. 2011 Mar 31;471(7340):667-9.

The Good Stewardship Working Group. The "Top 5" Lists in Primary Care: Meeting the Responsibility of
Professionalism. Arch Intern Med. 2011 May 23. [Epub ahead of print].

Whitstock MT, Pearce CM, Ridout SC, Eckermann EJ. Using clinical trial data and linked administrative
health data to reduce the risk of adverse events associated with the uptake of newly released drugs by
older Australians: a model process. BMC Public Health. 2011 May 21;11(1):361. [Epub ahead of print].

Kreps GL, Villagran MM, Zhao X et al. Development and validation of motivational messages to improve
prescription medication adherence for patients with chronic health problems. Patient Educ
Couns. 2011 May 20. [Epub ahead of print].

                                              Stats and Facts

Progress report 2011: Health care renewal in Canada. Toronto ON: Health Council of Canada; May

Lucado J, Paez K, Elixhauser A. Medication-related adverse outcomes in U.S. hospitals and emergency
departments, 2008. Statistical Brief [US Agency for Healthcare research and Quality]. 2011 Apr;#109:1-

Drug trend report: Healthcare 2020: Fast-forward to the future. Franklin Lake NJ: Medco Health
Solutions; 2011.
                             Substance Use & Substance-Related Disorders

Somaini L, Donnini C, Raggi MA et al. Promising Medications for Cocaine Dependence Treatment.
Recent Pat CNS Drug Discov. 2011 May 23. [Epub ahead of print].

The following two sides of a debate are related:

        Kahan M, Srivastava A, Conway B. Is there a need for heroin substitution treatment in
        Vancouver's Downtown Eastside? Can J Public Health. 2011 Mar-Apr;102(2):84-6.

        Schechter MT, Kendall P. Is there a need for heroin substitution treatment in Vancouver's
        Downtown Eastside? Yes there is, and in many other places too. Can J Public Health. 2011 Mar-

Sussman S, Lisha N, Griffiths M. Prevalence of the addictions: a problem of the majority or the minority?
Eval Health Prof. 2011 Mar;34(1):3-56. Epub 2010 Sep 27.

The following study and comment are related:

        Krupitsky E, Nunes EV, Ling W et al. Injectable extended-release naltrexone for opioid
        dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet. 2011 Apr

        Wolfe D, Carrieri MP, Dasgupta N et al. Concerns about injectable naltrexone for opioid
        dependence. Lancet. 2011 Apr 30;377(9776):1468-70.

The following study and comment are related:

        Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates
        from drug overdose. Pain Med. 2011 May;12(5):747-54. doi:10.1111/j.1526-4637.2011.01062.x.
        Epub 2011 Feb 18.

        Green TC, Zaller N, Rich J et al. Revisiting Paulozzi et al.'s "Prescription Drug Monitoring
        Programs and Death Rates from Drug Overdose". Pain Med. 2011 May 31. doi: 10.1111/j.1526-
        4637.2011.01136.x. [Epub ahead of print].

War on drugs: Report of the Global Commission on Drug Policy. Rio de Janeiro, Brazil: Global
Commission on Drug Policy; June 2011.

                    Surgery, Transplantation, Anesthesiology & Perioperative Care

Hanna GM, Levine WC. Medication safety in the perioperative setting. Anesthesiol Clin. 2011

Hernandez J, Goeckner B, Wanzer L. Perioperative pharmacology: pharmacotherapeutics,
pharmacokinetics, and pharmacodynamics. AORN J. 2011 Feb;93(2):259-66; quiz 267-9.
De Oliveira GS Jr, Theilken LS, McCarthy RJ. Shortage of Perioperative Drugs: Implications for Anesthesia
Practice and Patient Safety. Anesth Analg. 2011 May 19. [Epub ahead of print].

Cook-Norris RH, Michaels JD, Weaver AL et al. Complications of cutaneous surgery in patients taking
clopidogrel-containing anticoagulation. J Am Acad Dermatol. 2011 Apr 20. [Epub ahead of print].


Kaushal R, Kern LM, Barrón Y et al. Electronic prescribing improves medication safety in community-
based office practices. J Gen Intern Med. 2010 Jun;25(6):530-6. Epub 2010 Feb 26.

Coleman JJ, Hemming K, Nightingale PG et al. Can an electronic prescribing system detect doctors who
are more likely to make a serious prescribing error? J R Soc Med. 2011 May;104(5):208-18.

Granger BB, Bosworth HB. Medication adherence: emerging use of technology. Curr Opin Cardiol. 2011
May 19. [Epub ahead of print].

Classen DC, Phansalkar S, Bates DW. Critical drug-drug interactions for use in electronic health records
systems with computerized physician order entry: review of leading approaches. J Patient Saf. 2011

                                            Women’s Health

Yakin K, Urman B. DHEA as a miracle drug in the treatment of poor responders; hype or hope? Hum
Reprod. 2011 May 18. [Epub ahead of print].

Roush K. Menopausal hormone therapy: what we know now. Am J Nurs. 2011 Jun;111(6):38-47.

Warensjö E, Byberg L, Melhus H et al. Dietary calcium intake and risk of fracture and osteoporosis:
prospective longitudinal cohort study. BMJ. 2011 May 24;342:d1473. doi: 10.1136/bmj.d1473.

Gambacciani M, Rosano G, Cappagli B et al. Clinical and metabolic effects of drospirenone-estradiol in
menopausal women: a prospective study. Climacteric. 2011 Feb;14(1):18-24. Epub 2010 Oct 27.

                                       The End Until Next Time!!!

To top